<HTML>
<HEAD>
<TITLE>AutoCoded Document</TITLE>
</HEAD>
<BODY>


<!-- MARKER FORMAT-SHEET="Head Major" -->
<A NAME="A001"></A>
<P ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="4"><B>UNITED
STATES<BR>SECURITIES AND EXCHANGE COMMISSION</B><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B><BR>WASHINGTON,
D.C. 20549</B></FONT></FONT></FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Center Cutoff Line" -->
<P ALIGN="CENTER">_________________ </P>

<!-- MARKER FORMAT-SHEET="Head Major" -->
<A NAME="A004"></A>
<P ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>FORM
8-K</B></FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Head Major" -->
<A NAME="A005"></A>
<P ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>CURRENT
REPORT<BR>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</B></FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Head Major" -->
<A NAME="A006"></A>
<P ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>Date
of Report: &nbsp;&nbsp;&nbsp;March 5, 2007</B></FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Center" -->
<A NAME="A007"></A>
<P ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="4"><B>COGENCO
INTERNATIONAL INC.</B><BR><FONT SIZE="2">(Name of small business issuer as specified in its charter)</FONT></FONT></FONT> </P>


<TABLE cellSpacing=0 cellPadding=0 width=600 align=center>
 <TR vAlign=bottom>
    <TH colSpan=2><FONT face="Times New Roman, Times, Serif" size=2></FONT></TH>
    <TH colSpan=2><FONT face="Times New Roman, Times, Serif" size=2></FONT></TH>
    <TH colSpan=2><FONT face="Times New Roman, Times, Serif"
  size=2></FONT></TH></TR>
  <TR vAlign=bottom>
    <TD align=left width="37%"><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Colorado</B></FONT></TD>
    <TD align=left width="4%"><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;</FONT></TD>
    <TD align=left width="30%"><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>2-87052-D</B></FONT></TD>
    <TD align=left width="4%"><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;</FONT></TD>
    <TD align=left width="23%"><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>84-0194754</B></FONT></TD>
    <TD align=left width="2%"><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD align=left><FONT face="Times New Roman, Times, Serif" size=2>(State of Incorporation
      </FONT></TD>
    <TD align=left><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;</FONT></TD>
    <TD align=left><FONT face="Times New Roman, Times, Serif"
      size=2>Commission File Number</FONT></TD>
    <TD align=left><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;</FONT></TD>
    <TD align=center><FONT face="Times New Roman, Times, Serif" size=2>IRS
      Employer</FONT></TD>
    <TD align=left><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;</FONT></TD></TR>
  <TR vAlign=bottom>
    <TD align=left><FONT face="Times New Roman, Times, Serif" size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD align=left><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;</FONT></TD>
    <TD align=left><FONT face="Times New Roman, Times, Serif"
size=2></FONT></TD>
    <TD align=left><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;</FONT></TD>
    <TD align=left><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Identification Number</FONT></TD>
    <TD align=left><FONT face="Times New Roman, Times, Serif"
      size=2>&nbsp;</FONT></TD></TR></TABLE><BR><BR>

<!-- MARKER FORMAT-SHEET="Para Center" -->
<P ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>4085 South
Dexter Street<BR> Englewood, Colorado 80113</B><BR> Address of principal executive offices</FONT></FONT> </P>

<!-- MARKER FORMAT-SHEET="Para Center" -->
<P ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>303-758-1357</B>
<BR>Telephone number, including Area code</FONT></FONT> </P>

<!-- MARKER FORMAT-SHEET="Para Center" -->
<P ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>Not
applicable</B> <BR>Former name or former address if changed since last report</FONT></FONT> </P>

<!-- MARKER FORMAT-SHEET="Para Flush" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant  under any of the following provisions:</FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Hang Arabic" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD ALIGN="LEFT" WIDTH="3%"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">[&nbsp;&nbsp;&nbsp;]</FONT></FONT></TD>
     <TD WIDTH="97%"><P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;
Written communications pursuant to Rule 425 under the Securities Act</FONT></FONT> </P></TD>
</TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para Hang Arabic" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD ALIGN="LEFT" WIDTH="3%"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">[&nbsp;&nbsp;&nbsp;]</FONT></FONT></TD>
     <TD WIDTH="97%"><P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;
Soliciting material pursuant to Rule 14a-12 under the Exchange Act</FONT></FONT> </P></TD>
</TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para Hang Arabic" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD ALIGN="LEFT" WIDTH="3%"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">[&nbsp;&nbsp;&nbsp;]</FONT></FONT></TD>
     <TD WIDTH="97%"><P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act</FONT></FONT> </P></TD>
</TR>
</TABLE>

<!-- MARKER FORMAT-SHEET="Para Hang Arabic" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD ALIGN="LEFT" WIDTH="3%"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">[&nbsp;&nbsp;&nbsp;]</FONT></FONT></TD>
     <TD WIDTH="97%"><P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act</FONT></FONT> </P></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Flush" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">Indicate by
checkmark whether registrant is a shell company as defined in Rule 12b-2 of the Exchange
Act:&nbsp;&nbsp;  <B>XX</B></FONT></FONT></P>

<P style="PAGE-BREAK-BEFORE: always">
<HR align=center width="100%" color=#999999 SIZE=3>

<!-- *************************************************************************** -->
<!-- MARKER PAGE="sheet: 1; page: 1" -->


<!-- MARKER FORMAT-SHEET="Head Minor" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>Item 1.01
&#150; Entry Into a Material Definitive Agreement</B></FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Head Minor" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B><I>The Material
Definitive Agreement</I></B></FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
March 6, 2007 we entered into a Share Purchase Agreement (the &#147;Agreement&#148;) with
Genesis Investment Funds, Ltd  (&#147;Genesis&#148;), Trust House, 112 Bonadie Street,
Kingstown, Saint Vincent.</FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the Agreement and upon the completion of Genesis&#146; investment obligation, we will
issue to Genesis 75,000 shares  of our common stock at $10 per share.  Genesis will pay
the purchase price by tendering to our account at Basler Kantonalbank,  Zurich,
Switzerland, 500,000 shares of Helix Biopharma Corporation (&#147;Helix&#148;) common
stock.  Helix is a Canadian company whose common  shares are listed on the Toronto Stock
Exchange (HBP.TO).  Genesis has agreed that if the net proceeds of our sales of Helix
common  stock average less than $1.50 per share, upon written request, Genesis will
deposit additional shares of Helix stock (or other  publicly-traded shares reasonably
acceptable to Cogenco) into an account we designate.  We may request that Genesis deposit
additional shares at any time until March 5, 2008, when Genesis&#146;s obligation to
deposit additional shares terminates.  Based on  Cogenco&#146;s investigation, Cogenco
believes that it will be able to liquidate the Helix shares over a reasonable period of
time through  the facilities of the Toronto Stock Exchange.  Cogenco does not believe
that the ownership of the Helix shares will result in Cogenco  becoming an investment
company subject to regulation under the Investment Advisors Act of 1940, although there
can be no assurance  that the Securities and Exchange Commission may not take a different
position.</FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;When
received, we plan to use the proceeds of any sales of Helix stock to meet certain of our
obligations to DMI  Biosciences, Inc. (&#147;DMI&#148;) for the furtherance, or
acquisition, of business opportunities and for other corporate purposes,  including
working capital, and payment of accrued and future salaries for its executive officers.
Because Genesis has not yet  completed its transfer of the Helix shares to Cogenco, we
cannot offer any assurance as to when or whether we will receive those  shares or be able
to liquidate those shares if received.</FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Head Minor" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B><I>Genesis
Ownership Of Cogenco</I></B></FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to a discretionary investment management agreement, Genesis Capital Management has
discretionary investment and  voting control over the assets of Genesis Capital
Management Limited, including the shares of Cogenco common stock that Genesis  Investment
Funds Limited owns or controls directly and indirectly.  As of the date of our most
recent Form 10-KSB, Genesis had the  right to vote and dispose of approximately 42% of
Cogenco&#146;s outstanding common shares.  Since then, certain investors with interests
in Cogenco transferred their shares to Genesis for management purposes, our president
David Brenman transferred 220,000 shares of  common stock that he owned to Genesis (with
a commitment by Genesis Capital Management Ltd. to return those shares to Mr. Brenman in
the event of a successful conclusion to the transaction contemplated with DMI Biosciences
(as described in our Form 10-KSB) or other  appropriate business combination), and on
October 27, 2006, Genesis purchased an additional 2,500 shares of our common stock in a
private offering.</FONT></FONT></P>

<P style="PAGE-BREAK-BEFORE: always">
<HR align=center width="100%" color=#999999 SIZE=3>

<!-- *************************************************************************** -->
<!-- MARKER PAGE="sheet: 2; page: 2" -->

<!-- MARKER FORMAT-SHEET="Para Indent" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As
a result of those transactions and before the purchase described above is completed,
Genesis owns or controls 1,579,863  shares of Cogenco&#146;s outstanding common stock
(approximately 60%).  If Genesis completes the acquisition of the 75,000 shares, it will
increase its ownership of Cogenco to approximately 63%.</FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Head Minor" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B><I>Control of
Genesis</I></B></FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Genesis
is controlled by Genesis Capital Management Limited, a company controlled by Herald
A.M.A. Janssen and Petrus H.  Jacobs.  Mr. Janssen and Mr. Jacobs co-founded Genesis
Investment Funds Limited and Genesis Capital Management Limited, and appointed  Genesis
Capital Management as the investment advisor for Genesis Investment Funds Limited.</FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Until
January 1, 2007, Mr. Janssen also controlled MJM Asset Management Company Establishment (&#147;MJM&#148;),
a company he founded  in 1997.  Mr. Janssen no longer has any direct or indirect interest
in MJM.  During the period of Mr. Janssen&#146;s ownership, Cogenco  paid MJM Asset
Management a finders&#146; fee of 7&frac12;% of the $2,000,000 in funds raised by MJM
Asset Management for Cogenco.  Mr. Janssen&#146;s  address is Matschils 23, LI-9495
Triesen, Liechtenstein.  As disclosed in Cogenco&#146;s reports on Form 10-KSB for the
year ended March  31, 2006 and in certain subsequent reports, MJM paid one-third of the
finder&#146;s fee to David W. Brenman, president of Cogenco, in  accordance with an oral
agreement between them.  As a result of Mr. Janssen&#146;s sale of MJM, Mr. Brenman is
not entitled to receive any  further compensation from MJM&#146;s direct or indirect
investments in Cogenco.  Cogenco will not pay any third party (related or  otherwise) any
fee resulting from the investment of the Helix common stock in exchange for Cogenco
common stock.</FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Genesis
Investment Funds Limited is also controlled by Petrus H. Jacobs, a licensed European
property manager who holds a  degree in engineering from the Technical Institute,
Heerlen, Netherlands.  He is a certified appraiser by the court in the  Netherlands.  Mr.
Jacobs has been working as an asset manager in Europe since the 1980&#146;s and has from
time-to-time worked with Mr.  Janssen and MJM Asset Management.  Mr. Jacobs co-founded
Genesis Investment Funds Limited with Mr. Janssen.  Mr. Jacob&#146;s address is
Meierhofstrasse 85, LI-9495 Triesen, Liechtenstein.</FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Head Minor" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>Item 5.03
&#150; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year</B></FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On
March 5, 2007 we filed Restated Articles of Incorporation with the Colorado Secretary of
State.  Since filing our  original Articles of Incorporation in 1983 we have filed
several amendments to our Articles of Incorporation.  The Restated Articles  do not amend
our Articles of Incorporation, but instead were filed so that our Articles of
Incorporation are more readily available  and understandable to our shareholders.</FONT></FONT></P>

<P style="PAGE-BREAK-BEFORE: always">
<HR align=center width="100%" color=#999999 SIZE=3>


<!-- *************************************************************************** -->
<!-- MARKER PAGE="sheet: 3; page: 3" -->


<!-- MARKER FORMAT-SHEET="Head Minor" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>Item 9.01
&#150; Financial Statements and Exhibits</B></FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Hang Roman" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD ALIGN="RIGHT" WIDTH="3%"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">(a) </FONT></FONT></TD>
     <TD ALIGN="LEFT" WIDTH="3%">&nbsp;</TD>
     <TD WIDTH="94%"><P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"> Financial
Statements of Businesses Acquired.</FONT></FONT> </P></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Indent Level 1" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD WIDTH="3%">&nbsp;</TD>
     <TD WIDTH="97%"><P ALIGN="LEFT">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">Not
required.</FONT></FONT></P></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Hang Roman" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD ALIGN="RIGHT" WIDTH="3%"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">(b) </FONT></FONT></TD>
     <TD ALIGN="LEFT" WIDTH="3%">&nbsp;</TD>
     <TD WIDTH="94%"><P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"> Pro
forma financial information.</FONT></FONT> </P></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Indent Level 1" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD WIDTH="3%">&nbsp;</TD>
     <TD WIDTH="97%"><P ALIGN="LEFT">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">Not
required.</FONT></FONT></P></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Hang Roman" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD ALIGN="RIGHT" WIDTH="3%"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">(c) </FONT></FONT></TD>
     <TD ALIGN="LEFT" WIDTH="3%">&nbsp;</TD>
     <TD WIDTH="94%"><P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"> Exhibits</FONT></FONT> </P></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Indent Level 1" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD WIDTH="3%">&nbsp;</TD>
     <TD WIDTH="97%"><P ALIGN="LEFT">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">3.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Restated Articles of Incorporation</FONT></FONT></P></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Indent Level 1" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD WIDTH="3%">&nbsp;</TD>
     <TD WIDTH="97%"><P ALIGN="LEFT">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">10.1&nbsp;&nbsp;&nbsp;
Share Purchase Agreement dated March 6, 2007</FONT></FONT></P></TD>
</TR>
</TABLE>
<BR>


<!-- MARKER FORMAT-SHEET="Head Major" -->
<P ALIGN="CENTER"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>SIGNATURES</B></FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Indent" -->
<P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant caused this
report to be signed on its  behalf by the undersigned, thereunto duly authorized, on the
8th day of March 2007.</FONT></FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush In 2" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD WIDTH="50%">&nbsp;</TD>
     <TD><P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2"><B>Cogenco
International, Inc.</B></FONT></FONT> </P></TD>
</TR>
</TABLE>
<BR>

<!-- MARKER FORMAT-SHEET="Para Flush In 2" -->
<TABLE WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR VALIGN="TOP">
     <TD WIDTH="50%">&nbsp;</TD>
     <TD><P ALIGN="LEFT"><FONT FACE="Times New Roman, Times, Serif"><FONT SIZE="2">By:&nbsp;&nbsp;
/s/&nbsp;&nbsp;&nbsp; David W. Brenman  <BR>David W. Brenman  President</FONT></FONT> </P></TD>
</TR>
</TABLE>
<BR>





</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "cogenco8k352007.htm", "description": "FORM 8-K  (MARCH 5, 2007)", "secsgml_size_bytes": 20384}]
{"company-data": {"conformed-name": "COGENCO INTERNATIONAL INC", "cik": "0000730729", "assigned-sic": "8711", "irs-number": "840914754", "state-of-incorporation": "CO", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "002-87052-D", "film-number": "07683517"}, "business-address": {"street1": "1775 SHERMAN STREET", "street2": "SUITE 1001", "city": "DENVER", "state": "CO", "zip": "80203", "phone": "3038940234"}, "mail-address": {"street1": "1775 SHERMAN ST", "street2": "SUITE 1001", "city": "DENVER", "state": "CO", "zip": "80203"}}
AutoCoded Document
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
_________________
FORM
8-K
CURRENT
REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report:    March 5, 2007
COGENCO
INTERNATIONAL INC.
(Name of small business issuer as specified in its charter)
Colorado
2-87052-D
84-0194754
(State of Incorporation
Commission File Number
IRS
      Employer
Identification Number
4085 South
Dexter Street
Englewood, Colorado 80113
Address of principal executive offices
303-758-1357
Telephone number, including Area code
Not
applicable
Former name or former address if changed since last report
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant  under any of the following provisions:
[   ]
Written communications pursuant to Rule 425 under the Securities Act
[   ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
[   ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
[   ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
Indicate by
checkmark whether registrant is a shell company as defined in Rule 12b-2 of the Exchange
Act:
XX
Item 1.01
– Entry Into a Material Definitive Agreement
The Material
Definitive Agreement
On
March 6, 2007 we entered into a Share Purchase Agreement (the "Agreement") with
Genesis Investment Funds, Ltd  ("Genesis"), Trust House, 112 Bonadie Street,
Kingstown, Saint Vincent.
Pursuant
to the Agreement and upon the completion of Genesis' investment obligation, we will
issue to Genesis 75,000 shares  of our common stock at $10 per share.  Genesis will pay
the purchase price by tendering to our account at Basler Kantonalbank,  Zurich,
Switzerland, 500,000 shares of Helix Biopharma Corporation ("Helix") common
stock.  Helix is a Canadian company whose common  shares are listed on the Toronto Stock
Exchange (HBP.TO).  Genesis has agreed that if the net proceeds of our sales of Helix
common  stock average less than $1.50 per share, upon written request, Genesis will
deposit additional shares of Helix stock (or other  publicly-traded shares reasonably
acceptable to Cogenco) into an account we designate.  We may request that Genesis deposit
additional shares at any time until March 5, 2008, when Genesis's obligation to
deposit additional shares terminates.  Based on  Cogenco's investigation, Cogenco
believes that it will be able to liquidate the Helix shares over a reasonable period of
time through  the facilities of the Toronto Stock Exchange.  Cogenco does not believe
that the ownership of the Helix shares will result in Cogenco  becoming an investment
company subject to regulation under the Investment Advisors Act of 1940, although there
can be no assurance  that the Securities and Exchange Commission may not take a different
position.
When
received, we plan to use the proceeds of any sales of Helix stock to meet certain of our
obligations to DMI  Biosciences, Inc. ("DMI") for the furtherance, or
acquisition, of business opportunities and for other corporate purposes,  including
working capital, and payment of accrued and future salaries for its executive officers.
Because Genesis has not yet  completed its transfer of the Helix shares to Cogenco, we
cannot offer any assurance as to when or whether we will receive those  shares or be able
to liquidate those shares if received.
Genesis
Ownership Of Cogenco
Pursuant
to a discretionary investment management agreement, Genesis Capital Management has
discretionary investment and  voting control over the assets of Genesis Capital
Management Limited, including the shares of Cogenco common stock that Genesis  Investment
Funds Limited owns or controls directly and indirectly.  As of the date of our most
recent Form 10-KSB, Genesis had the  right to vote and dispose of approximately 42% of
Cogenco's outstanding common shares.  Since then, certain investors with interests
in Cogenco transferred their shares to Genesis for management purposes, our president
David Brenman transferred 220,000 shares of  common stock that he owned to Genesis (with
a commitment by Genesis Capital Management Ltd. to return those shares to Mr. Brenman in
the event of a successful conclusion to the transaction contemplated with DMI Biosciences
(as described in our Form 10-KSB) or other  appropriate business combination), and on
October 27, 2006, Genesis purchased an additional 2,500 shares of our common stock in a
private offering.
As
a result of those transactions and before the purchase described above is completed,
Genesis owns or controls 1,579,863  shares of Cogenco's outstanding common stock
(approximately 60%).  If Genesis completes the acquisition of the 75,000 shares, it will
increase its ownership of Cogenco to approximately 63%.
Control of
Genesis
Genesis
is controlled by Genesis Capital Management Limited, a company controlled by Herald
A.M.A. Janssen and Petrus H.  Jacobs.  Mr. Janssen and Mr. Jacobs co-founded Genesis
Investment Funds Limited and Genesis Capital Management Limited, and appointed  Genesis
Capital Management as the investment advisor for Genesis Investment Funds Limited.
Until
January 1, 2007, Mr. Janssen also controlled MJM Asset Management Company Establishment ("MJM"),
a company he founded  in 1997.  Mr. Janssen no longer has any direct or indirect interest
in MJM.  During the period of Mr. Janssen's ownership, Cogenco  paid MJM Asset
Management a finders' fee of 7½% of the $2,000,000 in funds raised by MJM
Asset Management for Cogenco.  Mr. Janssen's  address is Matschils 23, LI-9495
Triesen, Liechtenstein.  As disclosed in Cogenco's reports on Form 10-KSB for the
year ended March  31, 2006 and in certain subsequent reports, MJM paid one-third of the
finder's fee to David W. Brenman, president of Cogenco, in  accordance with an oral
agreement between them.  As a result of Mr. Janssen's sale of MJM, Mr. Brenman is
not entitled to receive any  further compensation from MJM's direct or indirect
investments in Cogenco.  Cogenco will not pay any third party (related or  otherwise) any
fee resulting from the investment of the Helix common stock in exchange for Cogenco
common stock.
Genesis
Investment Funds Limited is also controlled by Petrus H. Jacobs, a licensed European
property manager who holds a  degree in engineering from the Technical Institute,
Heerlen, Netherlands.  He is a certified appraiser by the court in the  Netherlands.  Mr.
Jacobs has been working as an asset manager in Europe since the 1980's and has from
time-to-time worked with Mr.  Janssen and MJM Asset Management.  Mr. Jacobs co-founded
Genesis Investment Funds Limited with Mr. Janssen.  Mr. Jacob's address is
Meierhofstrasse 85, LI-9495 Triesen, Liechtenstein.
Item 5.03
– Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
On
March 5, 2007 we filed Restated Articles of Incorporation with the Colorado Secretary of
State.  Since filing our  original Articles of Incorporation in 1983 we have filed
several amendments to our Articles of Incorporation.  The Restated Articles  do not amend
our Articles of Incorporation, but instead were filed so that our Articles of
Incorporation are more readily available  and understandable to our shareholders.
Item 9.01
– Financial Statements and Exhibits
(a)
Financial
Statements of Businesses Acquired.
Not
required.
(b)
Pro
forma financial information.
Not
required.
(c)
Exhibits
3.1     
Restated Articles of Incorporation
10.1   
Share Purchase Agreement dated March 6, 2007
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant caused this
report to be signed on its  behalf by the undersigned, thereunto duly authorized, on the
8th day of March 2007.
Cogenco
International, Inc.
By:  
/s/    David W. Brenman
David W. Brenman  President